BUY Indoco Remedies Limited — Nagaraj Shetty, HDFC Securities
byNagaraj Shetty, HDFC SecuritiesHorizon: 1–3 months15 Apr 2026via ET Now
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Indoco Remedies Limited's Goa plant successfully passed an audit by the Malta Medicines Authority on June 26, 2026. This indicates compliance and quality standards.
NSE · Press Release·26 Jun · 3w ago
1 advisor has an active long-term BUY call on this stock
Advisor consensus · adjacent horizon·10 May · 2mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Indoco Remedies
- BUY — Om Mehra, SAMCO Securities29 Sept 2026 · ~2 weeks · target ₹295 · SL hit
- SELL — Kunal Bothra9 Sept 2026 · ~2 weeks · target ₹225 · Expired
- BUY — Kunal Bothra28 Aug 2026 · ~2 weeks · target ₹268 · Target hit
- BUY — Kunal Parar, Choice Broking27 Aug 2026 · ~2 weeks · target ₹253 · Target hit
- BUY — ICICI Securities10 May 2026 · ~1 year · target ₹270 · Target hit
More from Nagaraj Shetty, HDFC Securities
- BUY Wipro21 Oct 2026 · ~3 months · target ₹202 · Active
- SELL Dixon Technologies (India)21 Oct 2026 · ~3 months · target ₹10,950 · Active
- BUY SAGILITY14 Oct 2026 · ~3 months · target ₹49.5 · SL hit
- BUY Rain Industries14 Oct 2026 · ~3 months · target ₹255 · SL hit
- BUY BIRLASOFT14 Oct 2026 · ~2 weeks · target ₹325 · Target hit

